US EditionPublished • loading... • Updated
Rhythm hits key milestone with first sale of ColoSTAT blood test for bowel cancer
Summary by Stockhead
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Rhythm hits key milestone with first sale of ColoSTAT blood test for bowel cancer
Rhythm completes the first commercial sale of its blood-based ColoSTAT colorectal cancer test Sale marks start of the company’s commercial clinical diagnostic testing operations First patient’s blood samples collected and transported to Rhythm’s clinical laboratory in Victoria Special Report: Rhythm Biosciences has reached a major milestone with the first commercial sale of its blood-based ColoSTAT colorectal cancer test, signalling the start …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
